Robert Glynn, PhD, ScD

Harvard Medical School, Brigham and Women's Hospital

Poster(s):

• (53) Cardiovascular Outcomes of GLP-1 Receptor Agonists Versus Metformin as First-Line Treatment for Type 2 Diabetes
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (AI) Comparative Risk of Opioid Overdose with Concomitant Use of Prescription Opioids and Skeletal Muscle Relaxants
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (R) Risk of Infection in Children with Psoriasis Receiving Treatment with Ustekinumab, Etanercept, or Methotrexate
  Sunday, August 28, 2022

  8:00 AM – 6:00 PM CEST

• (291) Propensity Score-Based Weighting Methods in The Context of Multiple Treatment Options
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (59) Risk of Falls and Fractures with Concomitant Use of Prescription Opioids and Other Medications in Osteoarthritis Patients
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST